Jacqueline E. Shea - 20 May 2025 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Chief Executive Officer, Director
Signature
/s/ Jacqueline E. Shea
Issuer symbol
INO
Transactions as of
20 May 2025
Net transactions value
$0
Form type
4
Filing time
21 May 2025, 16:58:59 UTC
Previous filing
16 May 2025
Next filing
27 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shea Jacqueline Elizabeth Chief Executive Officer, Director 660 W. GERMANTOWN PIKE, PLYMOUTH MEETING /s/ Jacqueline E. Shea 21 May 2025 0001771498

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Award $0 +84,888 $0.000000 84,888 20 May 2025 Common Stock 84,888 Direct F1
transaction INO Common Stock Option Award $0 +105,262 $0.000000 105,262 20 May 2025 Common Stock 105,262 $2.13 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 84,888 restricted stock units is as follows: 28,296 shares will vest on May 20, 2026; 28,296 shares will vest on May 20, 2027; and 28,296 shares will vest on May 20, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2 The vesting schedule for the 105,262 options is as follows: 52,631 shares will vest on May 20, 2027 and 52,631 shares will vest on May 20, 2028.